CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-04 | ZANTE GREG Chief Financial Officer | Sale | −15,000 | $17.90 | $269K | 180,730 |
| 2024-01-03 | Lian Brian President & CEO | Grant or award | +150,000 | 2,359,074 | ||
| 2024-01-03 | Lian Brian President & CEO | Shares withheld for taxes | −108,525 | $17.40 | $1.9M | 2,250,549 |
| 2024-01-03 | Lian Brian President & CEO | Grant or award | +160,000 | 2,410,549 | ||
| 2024-01-03 | Lian Brian President & CEO | Shares withheld for taxes | −106,115 | $17.40 | $1.8M | 2,304,434 |
| 2024-01-03 | Lian Brian President & CEO | Grant or award · Stock Option (Right to Buy) | +360,000 | 360,000 | ||
| 2024-01-03 | Mancini Marianna Chief Operating Officer | Grant or award | +28,334 | 327,208 | ||
| 2024-01-03 | Mancini Marianna Chief Operating Officer | Shares withheld for taxes | −16,533 | $17.40 | $288K | 310,675 |
| 2024-01-03 | Mancini Marianna Chief Operating Officer | Grant or award | +70,000 | 380,675 | ||
| 2024-01-03 | Mancini Marianna Chief Operating Officer | Shares withheld for taxes | −32,677 | $17.40 | $569K | 347,998 |
| 2024-01-03 | Mancini Marianna Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2024-01-03 | ZANTE GREG Chief Financial Officer | Grant or award | +28,334 | 188,724 | ||
| 2024-01-03 | ZANTE GREG Chief Financial Officer | Shares withheld for taxes | −18,233 | $17.40 | $317K | 170,491 |
| 2024-01-03 | ZANTE GREG Chief Financial Officer | Grant or award | +70,000 | 240,491 | ||
| 2024-01-03 | ZANTE GREG Chief Financial Officer | Shares withheld for taxes | −30,889 | $17.40 | $537K | 209,602 |
| 2024-01-03 | ZANTE GREG Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2024-01-02 | SINGLETON J MATTHEW Director | Grant or award · Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2024-01-02 | Rowland Charles A Jr Director | Grant or award · Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2024-01-02 | Rouan Sarah Kathryn Director | Grant or award · Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2024-01-02 | MACARTNEY LAWSON Director | Grant or award · Stock Option (Right to Buy) | +32,000 | 32,000 |
Page 12 of 27 · 528 trades